Neurology Specific Literature Search   
 
[home][thesaurus]
    

Differential
(Click to cross reference)
acid maltase deficiency
acid maltase deficiency, adult
Addison's disease
adrenoleukodystrophy
adrenoleukodystrophy, adult onset
adrenoleukodystrophy, carrier
adrenomyeloneuropathy
advances in neurology
adverse drug reaction
alpha glucosidase
alpha-synuclein
Alzheimer's disease
Alzheimer's disease, treatment of
anesthesia, general
anterior horn cell disease
arthritis
aspartate aminotransferase
asymptomatic
atidarsagene autotemcel
attention deficit disorder with hyperactivity
biologic markers
bone marrow transplantation
bradykinesia
calf hypertrophy
cardiomyopathy
carotid artery disease
cataracts
central nervous system, infection of
cerebrovascular accident
cerebrovascular disease
ceruloplasmin, serum
chelation therapy
children
choreoathetosis
chromosomal abnormality
chronic graft versus host disease
cirrhosis
clinical trials
coenzyme Q10 deficiency
complications
congestive heart failure
consanguinity
copper
copper metabolism, abnormal
cornea, abnormal
cornea, opacity of
creatine phosphokinase(CPK)elevated
cultured skin fibroblasts
degenerative diseases of CNS
delay in diagnosis
dementia, childhood
demyelinating disease
developmental retardation
diet
differential diagnosis
dysarthria
dysarthria-clumsy hand syndrome
dyskinesia
dysmorphic
dysphagia
dystonia
dystroglycanopathies
dystrophin
efficacy
electromyogram
Emery-Dreifuss muscular dystrophy
enzyme treatment
enzyme, defect
epidemiology of neurology
ethambutol
ethics in neurology
facial appearance, abnormal
fatty acid, elevated plasma content
fibrillations
gangliosidosis GM1
gangliosidosis GM2
Gaucher's disease
gene
gene mutation
gene therapy
genetic counselling
genetic diagnosis
genetic diagnosis, prenatal
genetic neurologic disorders
genetic screening
genetic testing
glioblastoma multiforme(astrocytoma Gr.III)
glutamic acid decarboxylase
glycogen storage disease
Gowers maneuver
hepatic failure
hepatitis
hepatolenticular degeneration(Wilson's disease)
hepatolenticular degeneration(Wilson's disease), screening for
hepatomegaly
hepatosplenomegaly
history of neurology
hormone replacement
Hurler's syndrome
hypogonadism
hypotonia
in situ hybridization
inborn errors of metabolism, screening
Kayser-Fleischer ring
Kearns-Sayre syndrome
Krabbe's disease
L-dopa
Leber's hereditary optic neuropathy
Leigh's disease
Lesch-Nyhan syndrome
leukemia
leukocyte enzyme abnormality
leukodystrophy
Lewy body
life expectancy
lipid storage disorder of CNS
liver disease
liver transplantation
Lorenzo's oil
low back pain
lysosomal storage disease
lysosomes, abnoral
MELAS syndrome
MERRF syndrome
metachromatic leukodystrophy
metachromatic leukodystrophy, juvenile
metachromatic leukodystrophy, late-infantile
mimics
misdiagnosis
mitochondrial disease
mitochondrial encephalomyopathy
MNGIE syndrome
molecular genetics
mortality
motor neuron disease
motor system
MRI
MRI, abnormal
MRI, muscle
mucopolysaccharidoses
multiple sclerosis, misdiagnosis
muscle biopsy
muscle wasting, diffuse
muscle weakness
muscular dystrophy
muscular dystrophy, Becker
muscular dystrophy, Becker, carrier
muscular dystrophy, cardiovascular changes with
muscular dystrophy, central nervous system abnormality
muscular dystrophy, classification
muscular dystrophy, congenital
muscular dystrophy, Duchenne
muscular dystrophy, Duchenne, carrier
muscular dystrophy, facioscapulohumeral
muscular dystrophy, limb-girdle
myelodysplasia
myoblast transfer
myopathy
myopathy, genetic
myopathy, mitochondrial
myopathy, quadriceps
myotonic discharges
neonatal screening, genetic neurologic disorders
neoplasm, primary intracerebral
neoplasm, primary of CNS
neoplasm, primary of CNS-recurrent
neoplasm, primary of CNS-treatment of
neuroleptic, atypical
neurologic disease
neurologic disease, diagnoses of
neurologic signs
neuropathy, ataxia, retinitis pigmentosa
Niemann-Pick disease
ophthalmoplegia, progressive external
pain, back
pancreatitis
paraparesis, spastic
paraspinal muscle
Parkinson disease
Parkinson disease, etiology of
Parkinson disease, nonmotor problems of
Parkinson disease, on-off phenomena in
Parkinson disease, pathogenesis of
Parkinson disease, surgical treatment of
Parkinson disease, treatment of
peroxisomal disease
polymerase chain reaction
Pompe's disease of glycogen storage
preclinical
prenatal diagnosis by amniocentesis
prevention of neurologic disorders
prognosis
progressive neurologic disorder
ProSavin
psychiatric problems in neurologic disorders
quality of life
respirator
respiratory failure
review article
rigidity
rippling muscle disease
safety
scoliosis
screening
seizure
sham surgery
short stature
sinemet
skin, biopsy
skin, darkening of
SMN1 gene
spinal muscular atrophy
spinal muscular atrophy, classification
stem cell transplantation
steroid
steroid therapy, CNS treatment and complications with
stimulation, deep brain
subarachnoid hemorrhage
subthalamic nucleus
survival motor neuron gene
synucleinopathy
systemic illness
testicular atrophy
toe walking
tongue, enlarged
treatment of neurologic disorder
tremor
very long chain fatty acids
viral infection
viral infection, CNS
weakness
weakness, progressive
weakness, proximal
web sites
Werdnig-Hoffman disease
white matter disease
Showing articles 1350 to 1400 of 11844 << Previous Next >>

A 46-year-old man with Persistent Hiccups, Cognitive Dysfunction, and Imbalance
Neurol 89:e193-e196, Lamb, C.J.,et al, 2017

MR Neurography for the Diagnosis of Hypertrophic Neuropathies
Neurol 89:e201, Sgobbi de Souza, P.V.,et al, 2017

Clinicopathologic Conference, Eosinophilic Granulomatosis with Polyangiitis
NEJM 377:1569-1578, Case 32-2017, 2017

Quality Improvement in Neurology: Inpatient and Emergency Care Quality Measure Set
Neurol 89:730-735, Josephson, S.An.,et al, 2017

Long-Term Antithrombotic Treatment in Intracranial Hemorrhage Survivors with Atrial Fibrillation
Neurol 89:687-696, Korompoki, E.,et al, 2017

Effect of Gluten-Free Diet on Cerebellar MR Spectroscopy in Gluten Ataxia
Neurol 89:705-709, Hadjivassiliou, M.,et al, 2017

Migraine
NEJM 377:553-561, Charles, A., 2017

Gabapentin and Pregabalin for Pain - Is Increased Prescribing a Cause for Concern?
NEJM 377:411-414, Goodman, C.W. & Brett, A.S., 2017

Idarucizumab for Dabigatran Reversal - Full Cohort Analysis
NEJM 377:431-441, Pollack, C.V.,et al, 2017

CT Angiography ASPECTS Predicts Outcome Much Better Than Noncontrast CT in Patients with Stroke Treated Endovascularly
AJNR 38:1569-1573, Sallustio, F.,et al, 2017

Treatment of Cryptogenic Stroke with Active Cancer with a New Oral Anticoagulant
J Stroke Cerebrovasc Dis 26:2976-2980, Nam, K.W.,et al, 2017

Surgery for Drug-Resistant Epilepsy in Children
NEJM 377:1639-1647, Dwivedi, R.,et al, 2017

Direct Mechanical Thrombectomy Versus Combined Intravenous and Mechanical Thrombectomy in Large-Artery Anterior Circulation Stroke
Stroke 48:2912-2918, Fischer, U.,et al, 2017

Safety of Simultaneous Coronary Artery Bypass Grafting and Carotid Endarterectomy Versus Isolated Coronary Artery Bypass Grafting
Stroke 48:2769-2775, Weimar, C.,et al, 2017

A Case of Ataxia, Seizure, and Choreoathetosis in a 34-year-old Woman
Neurol 89:e220-e223, Xiao, F. & Wang, X.F., 2017

Nusinersen Versus Sham Control in Infantile-Onset Spinal Muscular Atrophy
NEJM 377:1723-1732,1786, Finkel, R.S.,et al, 2017

Maternal Use of antiepileptic Agents During Pregnancy and Major Congenital Malformations in Children
JAMA 318:1700-1701, Bromley, R.L.,et al, 2017

Increasing Prevalence of Vascular Risk Factors in Patients with Stroke
Neurol 89:1985-1994, Otite, F.O.,et al, 2017

Clinical Pathologic Conference, West Nile Virus Encephalitis
NEJM 377:1878-1886, Case 34-2017, 2017

Infliximab for the Treatment of CNS Sarcoidosis
Neurol 89:2092-2100, Gelfand, J.M.,et al, 2017

Clinical Imaging Factors Associated with Infarct Progression in Patients with Ischemic Stroke During Transfer for Mechanical Thrombectomy
JAMA Neurol 74:1361-1367,1298, Boulouis, G.,et al, 2017

Clinicopathologic Conference, Copper Deficiency Myelopathy
NEJM 377:1977-1984, Case 35-2017, 2017

An 82-year-old man with Worsening Gait
Neurol 89:e246-e252, Chew, S.,et al, 2017

Should Patients with Ischemic Stroke or Transient Ischemic Attack with Atrial Fibrillation and Microbleeds be Anticoagulated?
Stroke 48:3408-3412, Shoamanesh, A.,et al, 2017

Treatment and Outcome of Hemorrhagic Transformation after Intravenous Alteplase in Acute Ischemic Stroke
Stroke 48:e343-e361, Yaghi, S.,et al, 2017

Mobile Interventional Stroke Teams Lead to Faster Treatment Times for Thrombectomy in Large Vessel Occlusion
Stroke 48:3295-3300, Wei, D.,et al, 2017

Low-Dose Aspirin and Risk of Intracranial Bleeds
Neurol 89:2280-2287, Soriano, L.C.,et al, 2017

A 61-year-old woman with Lower Extremity Paralysis and Sensory Loss
Neurol 89:e257-e263, Manners, J.,et al, 2017

Overview of IgG4-related Disease
UptoDate, July, Moutsopoulos,H.,et al, 2017

A 50-year-old Woman with SLE and a Tumefactive Lesion
Neurol 89:e140-e145, Choi, J.H.,et al, 2017

A Case of Altered Mental Status, Not Otherwise Specified
Neurol 89:e154-e158, Swor, D.E.,et al, 2017

Thalamic Deep Brain Stimulation for Tremor in Parkinson Disease, Essential Tremor, and Dystonia
Neurol 89:1416-1423, Cury, R.G.,et al, 2017

Diagnostic Challenges in a Young Patient with Hypereosinophilia
Neurol 89:e159-e165, Ortiz, J.G.,et al, 2017

Long-Term Outcomes of Patent Foramen Ovale Closure or Medical Therapy after Stroke
NEJM 377:1022-1032,1006,1093, Saver, J.L.,et al, 2017

Patent Foramen Ovale Closure or Anticoagulation Vs. Antiplatelets after Stroke
NEJM 377:1011-1021,1006,1093, Mas, J.L,et al, 2017

Patent Foramen Ovale Closure or Antiplatelet Therapy for Cryptogenic Stroke
NEJM 377:1033-1042,1006,1093, Sondergaard, L.,et al, 2017

Alemtuzumab CARE-MS I 5-year follow-up
Neurol 89:1107-1116, Havrdova, E.,et al, 2017

Alemtuzumab CARE-MS II 5-year follow-up
Neurol 89:1117-1126, Coles, A.J.,et al, 2017

National Randomized Controlled Trial of Virtual House Calls for Parkinson Disease
Neurol 89:1152-1161,1103, Beck, C.A.,et al, 2017

Zolpidem for the Treatment of Neurologic Disorders
JAMA Neurol 74:1130-1139, Bomalaski, M.N.,et al, 2017

Management of Parkinson Disease in 2017
JAMA 318:791-792, Okun, M.S.,et al, 2017

Rituximab as Treatment for anti-MuSK myasthenia gravis
Neurol 89:1069-1077, Hehir, M.K.,et al, 2017

Chess Study Revives Debate Over Cognition-Enhancing Drugs
JAMA doi:10.1001/JAMA:2017.8114, Lyon, J., 2017

DAWN: Thrombectomy Effective Up to 24 Hours after Stroke
Medscape May, Hughes, S., 2017

Computed Tomographic Perfusion to Predict Response to Recanalization in Ischemic Stroke
Ann Neurol 81:849-856, Lansberg, M.G.,et al, 2017

A Man with Rapidly Ascending Paralysis
Neurol 89:e25-e31, Rosenberg, J.,et al, 2017

Carotid Stenosis Role of Plaque Morphology in Recurrent Stroke Risk
Stroke 48:e197-e199, Silverman, S. & Sundararajan, S., 2017

Subarachnoid Hemorrhage
NEJM 377:257-266, Lawton, M.T. & Vates, G.E., 2017

Intravenous Immune Globulin: Adverse Effects
UptoDate June, Perez, E.E. & Silvergleid, A.J., 2017

Lumbar Puncture Test in Normal Pressure Hydrocephalus: Does the Volume of CSF Removed Affect the Response to Tap?
AJNR 38:1456-1460, Thakur, S.K., et al, 2017



Showing articles 1350 to 1400 of 11844 << Previous Next >>